TRCT
TARO

Tower Research Capital (TRC)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Tower Research Capital (TRC)’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-119
Closed -$5.04K – 6110
2024
Q1 		$5.04K Sell
119
-262
-69% -$11K ﹤0.01% 4593
2023
Q4 		$15.9K Buy
381
+72
+23% +$2.65K ﹤0.01% 3804
2023
Q3 		$11.7K Sell
309
-726
-70% -$27.2K ﹤0.01% 3968
2023
Q2 		$39.3K Buy
1,035
+1,018
+5,988% +$32K ﹤0.01% 2789
2023
Q1 		$0 Buy
+17
New +$496 ﹤0.01% 6466
2022
Q4 		– Sell
-107
Closed -$3K – 6550
2022
Q3 		$3K Sell
107
-33
-24% -$1.14K ﹤0.01% 5452
2022
Q2 		$5K Buy
140
+136
+3,400% +$5.18K ﹤0.01% 5127
2022
Q1 		$0 Sell
4
-31
-89% -$1.45K ﹤0.01% 6720
2021
Q4 		$2K Buy
35
+30
+600% +$1.68K ﹤0.01% 5699
2021
Q3 		$0 Sell
5
-2,419
-100% -$167K ﹤0.01% 6297
2021
Q2 		$174K Buy
2,424
+685
+39% +$50.3K ﹤0.01% 2024
2021
Q1 		$128K Buy
1,739
+1,427
+457% +$108K ﹤0.01% 2386
2020
Q4 		$23K Sell
312
-77
-20% -$4.95K ﹤0.01% 3788
2020
Q3 		$21K Buy
389
+195
+101% +$12.1K ﹤0.01% 3856
2020
Q2 		$13K Sell
194
-46
-19% -$3.08K ﹤0.01% 3911
2020
Q1 		$15K Sell
240
-1,740
-88% -$129K ﹤0.01% 1856
2019
Q4 		$174K Buy
1,980
+1,883
+1,941% +$159K 0.01% 647
2019
Q3 		$7K Sell
97
-3,713
-97% -$301K ﹤0.01% 3166
2019
Q2 		$325K Buy
3,810
+3,176
+501% +$314K 0.02% 652
2019
Q1 		$69K Sell
634
-7,484
-92% -$745K ﹤0.01% 1607
2018
Q4 		$687K Buy
8,118
+6,634
+447% +$639K 0.05% 345
2018
Q3 		$146K Sell
1,484
-318
-18% -$34.4K 0.01% 1150
2018
Q2 		$208K Sell
1,802
-3,747
-68% -$412K 0.01% 1052
2018
Q1 		$548K Buy
5,549
+2,554
+85% +$259K 0.05% 431
2017
Q4 		$314K Buy
2,995
+1,913
+177% +$210K 0.04% 426
2017
Q3 		$122K Buy
+1,082
New +$118K 0.01% 1171
2017
Q2 		– Sell
-2,224
Closed -$259K – 3600
2017
Q1 		$259K Buy
2,224
+2,204
+11,020% +$244K 0.03% 249
2016
Q4 		$2K Sell
20
-142
-88% -$14.9K ﹤0.01% 3490
2016
Q3 		$18K Sell
162
-120
-43% -$15.9K ﹤0.01% 1691
2016
Q2 		$41K Buy
282
+137
+94% +$19.4K ﹤0.01% 1707
2016
Q1 		$21K Buy
+145
New +$20.6K ﹤0.01% 1315
2015
Q4 		– Sell
-35
Closed -$5K – 5172
2015
Q3 		$5K Buy
35
+23
+192% +$3.22K ﹤0.01% 2836
2015
Q2 		$2K Buy
+12
New +$1.71K ﹤0.01% 3810
2014
Q1 		– Sell
-576
Closed -$57K – 5041
2013
Q4 		$57K Buy
576
+476
+476% +$41.3K 0.01% 1278
2013
Q3 		$8K Sell
100
-282
-74% -$18.3K ﹤0.01% 3379
2013
Q2 		$21K Buy
+382
New +$22.6K ﹤0.01% 1668

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Tower Research Capital (TRC)'s TARO Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 119 shares — an estimated $5.04K sold.

Tower Research Capital (TRC) first reported a position in TARO in Q2 2013 and held it in 36 quarters. The position peaked at $687K in Q4 2018. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 119 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $5.04K.
  • Tower Research Capital (TRC) first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 36 quarters.
  • Tower Research Capital (TRC)'s Taro Pharmaceutical Industries Ltd. position peaked at $687K in Q4 2018.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.